Decentralized Clinical Trials (DCTs) redefine the landscape of clinical research by leveraging local or mobile healthcare providers to conduct remote study visits, procedures, and data collection in convenient locations for the patient, such as the comfort of their own home, offering a patient-centric approach and broadening the reach of the study.
ProPharma specializes in providing bespoke DCT services for every trial utilizing either a hybrid or fully virtual model to test your device or drug.
Decentralized clinical trials revolutionize traditional trial methodologies by bringing trial activities and medical technology directly to patients, reducing or eliminating the need for patients to visit traditional brick and mortar sites. This patient-centric approach lessens patient burden, enhances recruitment and retention rates, and ensures diverse participant inclusion allowing for trials to be therapeutically agnostic.
In addition, DCTs promote the use of technology, such as medical devices and telehealth visits, by offering 24/7 patient support and training. Our DCT model extends the site’s geographical reach and prioritizes patient experience while delivering reliable and real-time data to sponsors. This flexible approach also helps drive down sponsor costs and reduce trial timelines. With ProPharma’s team of GoClinical Clinicians who specialize in home health visits and are trained on GCP, IATA, and protocol-specific procedures, patients have the option to complete the trial in the most convenient location for them.
Our decentralized visits encompass a multitude of critical trial procedures, ensuring success. Our capabilities include:
Experience streamlined success with GoClinical, ProPharma's proprietary eSource system. Our platform enables clinicians to record and submit data in real-time, dramatically reducing source turnaround times and speeding up data entry into the EDC system. By using GoClinical, we minimize documentation errors, enhance PI oversight, and ensure greater safety in clinical trials. GoClinical makes data management faster, more accurate, and more efficient.
While Hybrid Clinical Trials are preferred by most sponsors, our team is adept at supporting both Hybrid and Virtual models. Unsure where to start? With over a decade of experience in the decentralized clinical trial space, our experts can guide your company through the selection process, ensuring the right fit for your study.
Vice President, Decentralized Clinical Trials
View Bio
Associate Director, Decentralized Clinical Trial Management
View Bio
October 2, 2025
Discover how ProPharma's medical information services in the Netherlands ensure patient safety, regulatory compliance, and data privacy with expert support.
September 30, 2025
Discover essential tips for preparing a successful FDA 510(k) submission. Learn common pitfalls to avoid, align with FDA expectations, and streamline your path to clearance.
September 26, 2025
Insights from FDA’s latest round of compliance letters which indicates a major shift in ad promo oversight revealing new compliance risks for Sponsors.
July 8, 2025
ProPharma appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...
January 31, 2025
ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.
October 21, 2024
ProPharma appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.
-chcecklist-complete-guide-fda-510k-submissions-ppg.png?width=320&height=185&name=510(k)-chcecklist-complete-guide-fda-510k-submissions-ppg.png)
